US Stock MarketDetailed Quotes

GKOS Glaukos

Watchlist

85.705
+2.165+2.59%

Trading May 2 10:01 ET

4.90BMarket Cap-37.76P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

A Quick Look at Today's Ratings for Glaukos(GKOS.US), With a Forecast Between $100 to $165
Moomoo News09:00 ET · Ratings
Glaukos Corp. Reports Record Revenue and Growth
TipRanks20:45 ET
Those Who Invested in Glaukos (NYSE:GKOS) Five Years Ago Are up 132%
Simply Wall St15:08 ET
This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Benzinga13:40 ET
Express News | Stifel Maintains Buy on Glaukos, Lowers Price Target to $115
Benzinga12:07 ET
Glaukos Falls -15.3%
TipRanks12:06 ET

Comments

Teddy123

Mar 11 19:13

RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution

$Glaukos (GKOS.US)$
Glaukos Unveils Game-Changing Vision Diagnostic Wearable: First-Ever Platform for Glaucoma Testing

Teddy123

Feb 24 20:16

Glaukos Announces FDA Acceptance of NDA Submission for Epioxa

$Glaukos (GKOS.US)$
Revolutionary Eye Treatment Advances: Can Glaukos Transform Keratoconus Care Without Surgery?

Moomoo AI

Jan 21, 2024 22:51

Glaukos' revenue growth is the market's focus due to its unprofitability. The 88% share price gain is solid, not standout. Market sentiment is lukewarm, hinting at potential stronger growth trends. Recent sentiment is positive due to strong share price momentum.

Investors Bid Glaukos (NYSE:GKOS) up US$137m Despite Increasing Losses YoY, Taking One-year Return to 88%

Meltyy

Dec 19, 2023 15:33

PDUFA Update…

Last week’s PDUFAs:
$Arcutis Biotherapeutics (ARQT.US)$ : Approved 12/15
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$Merck & Co (MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos (GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$Merck & Co (MRK.US)$ : Approved ...